- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-K Annual report
- 10.323 Pharmacopeia, Inc. 2000 Stock Option Plan
- 10.324 Collaboration and License Agreement
- 10.325 Collaboration and License Agreement
- 10.327 Lease Between Pharmacopeia, Inc. and Eastpark at 8A
- 10.329 Lease Between Pharmacopeia, Inc. and Eastpark at 8A
- 10.346 License Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm - Grant Thornton LLP
- 23.2 Consent of Independent Registered Public Accounting Firm - Bdo Seidman, LLP
- 31.1 Section 302 Certification by Principal Executive Officer
- 31.2 Section 302 Certification by Principal Financial Officer
- 32.1 Section 906 Certification by Principal Executive Officer
- 32.2 Section 906 Certification by Principal Financial Officer
Exhibit 32.2
CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Annual Report on Form 10-K of Ligand Pharmaceuticals Incorporated (the “Company”) for the year ended December 31, 2008, I, John P. Sharp, Vice President, Finance and Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
(1) such Annual Report on Form 10-K for the year ended December 31, 2008, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) the information contained in such Annual Report on Form 10-K for the year ended December 31, 2008, fairly presents, in all material respects, the financial condition and results of operations of the Company.
The foregoing certification is being furnished solely to accompany such Annual Report on Form 10-K for the year ended December 31, 2008, pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
Date: March 13, 2009 | /s/ JOHN P. SHARP | |
John P. Sharp Vice President, Finance and Chief Financial Officer (Principal Financial Officer) |